The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Trial Profile

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 19 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top